Quick Answer
QIAGEN N.V. reported Stockholders Equity of $3.78 billion for fiscal year 2025.
QIAGEN N.V. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $3.78B | +5.9% |
| 2024 | $3.57B | -6.3% |
| 2023 | $3.81B | +9.8% |
| 2022 | $3.47B | +12.0% |
| 2021 | $3.10B | +10.7% |
| 2020 | $2.80B | +10.3% |
| 2019 | $2.54B | -3.7% |
| 2018 | $2.63B | +3.7% |
| 2017 | $2.54B | -2.5% |
| 2016 | $2.61B | +1.6% |
| 2015 | $2.57B | -3.2% |
| 2014 | $2.65B | -2.4% |
| 2013 | $2.71B | -0.0% |
| 2012 | $2.71B | +6.5% |
| 2011 | $2.55B | +2.9% |
| 2010 | $2.48B | +8.1% |
| 2009 | $2.29B | +57.6% |
| 2008 | $1.45B | +4.5% |
| 2007 | $1.39B | — |
- QIAGEN N.V. showed an increase of +5.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2007–2025 period, QIAGEN N.V.’s stockholders equity has grown by 171.5% (from $1.39 billion to $3.78 billion).
- The most recent figure is from QIAGEN N.V.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: